UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015318
Receipt No. R000016903
Official scientific title of the study SubstanceP and postoperative nausea and vimiting
Date of disclosure of the study information 2014/10/02
Last modified on 2016/10/18 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study SubstanceP and postoperative nausea and vimiting
Title of the study (Brief title) SubstanceP and postoperative nausea and vimiting
Region
Japan

Condition
Condition postoperative nausea and vomiting
Classification by specialty
Anesthesiology Operative medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We investigated the relationship between postoperative nausea and vomiting(PONV) and substanceP.
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Episodes of nausea and vomiting
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine Maneuver Other
Interventions/Control_1 We measured plasma levels of substanceP on the day before operation, intraoperative pediod and postoperative period.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Eligible patients meet the criteria of American Society of Anesthesiologists(ASA)physical status of I-II.
Key exclusion criteria Patients are excluded the criteria of American Society of Anesthesiologists(ASA)physical status of over III.
Target sample size 30

Research contact person
Name of lead principal investigator Yasuo Tsutsumi
Organization Tokushima University Hospital
Division name Anesthesiology
Address Kuramoto 3-18-15, Tokushima 770-8503, Japan
TEL 088-633-7181
Email tsutsumi@tokushima-u.ac.jp

Public contact
Name of contact person Nami Kakuta
Organization Tokushima University Hospital
Division name Anesthesiology
Address Kuramoto 3-18-15, Tokushima 770-8503, Japan
TEL 088-633-7181
Homepage URL
Email kakuta.nami@tokushima-u.ac.jp

Sponsor
Institute Department of Anesthesiology, Tokushima University Hospital
Institute
Department

Funding Source
Organization Tokushima University Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 02 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 04 Month 01 Day
Anticipated trial start date
2014 Year 04 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 02 Day
Last modified on
2016 Year 10 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016903